Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year Publication Journal of Diabetes Science and Technology Date January 2018 Authors Bruce Bode,1 John G. Clarke,1 Joseph Johnson1 ABSTRACT Purpose: The purpose was to improve the quality of care of at-risk patients through the addition of connected BG meters and CDSS to improve workflow …
Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System
Safely Converting an Entire Academic Medical Center From Sliding Scale to Basal Bolus Insulin via Implementation of the eGlycemic Management System Publication Journal of Diabetes Science and Technology Date January 2018 Authors Rosalina Newsom,1 Christopher Patty,1 Emma Camarena,1 Regina Sawyer,1 Raymie McFarland,2 Thomas Gray,1 Melanie Mabrey2 ABSTRACT Objective: Hyperglycemia is common in the inpatient setting and providers frequently rely on …
November 3, 2017
Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing
Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing Presentation Annual Diabetes Technology Meeting Date November 2017 Authors Jagdeesh Ullal, Raymie McFarland, H. Courtenay Harrison, Amy Bedingfield, Jessica Sheehan, Susan DeAbate, Christine Dignan, Rebecca Cwik, Genevieve Thompson, Paul Chidester INTRODUCTION This prospective quality improvement project evaluated the effectiveness an electronic glycemic management system (eGMS®) utilizing Glucommander™ and admission …
September 12, 2017
Use of Decision Support Software To Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year
Use of Decision Support Software To Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year Presentation European Association for the Study of Diabetes Annual Meeting Date September 2017 Authors Andrew Rhinehart, John Clarke, Robby Booth INTRODUCTION Multiple issues continue to plague diabetes management: High insulin attrition rates1 Ineffective doses of insulin and insufficient dose adjustments2 Insufficient adult endocrinologists …
June 11, 2017
Safely Converting From Sliding Scale to Basal Bolus Insulin Across an Entire Medical Center via Implementation of the eGlycemic Management System
Safely Converting From Sliding Scale to Basal Bolus Insulin Across an Entire Medical Center via Implementation of the eGlycemic Management System Reduction in Hypoglycemic Events: 2,434 fewer hypoglycemic events with GM versus UC, resulting in savings of $7,141,356 over the first year, or $2,934 per event. Reduction in Average Length of Stay: 1.67 fewer days, resulting in savings over the …
May 19, 2017
Implementation of the eGlycemic Management System A Medical Center Case Study
Implementation of the eGlycemic Management System: A Medical Center Case Study Presentation International Hospital Diabetes Meeting Date May 2017 Authors Rosalina Newsom, Christopher Patty, Emma Camarena, Thomas Gray, Regina Sawyer, Brian Brown, Raymie McFarland BACKGROUND Hyperglycemia affects up to 40% of hospitalized patients and is associated with poor outcomes, including increased mortality, length of stay and surgical site infections. The …
May 4, 2017
“AUTO Study” AUtomatic Titration tO Target Subcutaneous Basal Bolus Insulin Management Using eGMS in the Non-ICU Setting
“AUTO Study” AUtomatic Titration tO Target: Subcutaneous Basal Bolus Insulin Management Using eGMS in the Non-ICU Setting Presentation American Association of Clinical Endocrinologists Scientific & Clinical Congress Date May 2017 Authors Joseph Aloi,1 Jagdeesh Ullal,2,3 Paul Chidester,3 Raymie McFarland4 BACKGROUND Hyperglycemia affects 30-40% of hospitalized patients and can be linked to poor outcomes, including increased mortality, longer length of hospitalization, …
February 15, 2017
Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen
Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2017 Authors Bruce Bode,1 Courtenay Harrison2 OBJECTIVE The importance of inpatient glycemic control on outcomes not only applies to patients managed with IV insulin in critical care areas but also patients on general surgical and …
Glucommander Outpatient, a Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months
Glucommander Outpatient, A Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2017 Authors Bruce Bode,1 John Clarke1 BACKGROUND Treatment of diabetes with multiple daily injections (MDI), using a regimen of long-acting basal and rapid-acting bolus …
November 10, 2016
Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During the Implementation of a System Wide Glycemic Initiative
Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During the Implementation of a System Wide Glycemic Initiative Presentation Annual Diabetes Technology Meeting Date November 2016 Authors April Mumpower,1 Suqin Hou,2 Tamera Parsons,1 Raymie McFarland2 OBJECTIVE The CMS Hospital Readmission Reduction (HRR) program was initiated in 2012 to encourage hospitals …
Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG?
Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG? Presentation Annual Diabetes Technology Meeting Date November 2016 Authors April Mumpower,1 Tamera Parsons1 OBJECTIVE The CMS Hospital Readmission Reduction (HRR) program added Coronary Artery Bypass Grafting (CABG) to their list of diagnoses that will be measured beginning in October 2016. Hospitals will be penalized for readmission rates …
August 23, 2016
Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting
Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting Publication Journal of Diabetes Science and Technology Date August 2016 Authors Joseph Aloi,1 Bruce Bode,2 Jagdeesh Ullal,3 Paul Chidester,4 Raymie McFarland,5 Amy Bedingfield,5 Melanie Mabrey,5 Robby Booth,5 April Mumpower,6 Amisha Wallia7 ABSTRACT Background: American Diabetes Association (ADA) guidelines recommend a basal bolus …
June 12, 2016
Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points
Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors John Clarke, Bruce Bode, Robby Booth, Harry Hebblewhite BACKGROUND Treatment of diabetes with multiple daily injections, using a regimen of basal and rapid-acting insulins is widely accepted as the standard of care. …
May 26, 2016
Improved Inpatient Hypoglycemia Rates With Electronic Glycemic Management System
Improved Inpatient Hypoglycemia Rates With Electronic Glycemic Management System Presentation American Association of Clinical Endocrinologists Scientific & Clinical Congress Date May 2016 Authors Joseph Aloi,1 Paul Chidester,2 Amy Henderson,3 Robby Booth,3 Raymie McFarland,3 April Mumford,4 Jagdeesh Ullal5 Background Hypoglycemia is a common adverse event for patients treated with insulin in the hospital setting, and is often considered the rate-limiting step …
October 22, 2015
eGlycemic Management System Provides Safe and Effective Glycemic Control for Stroke Patients Requiring Subcutaneous Insulin in the Hospital Setting
eGlycemic Management System Provides Safe and Effective Glycemic Control for Stroke Patients Requiring Subcutaneous Insulin in the Hospital Setting Presentation Annual Diabetes Technology Meeting Date October 2015 Authors Jagdeesh Ullal, Melanie Mabrey, Amy Henderson, Raymie McFarland, Robby Booth, Joseph Aloi Objective Admission hyperglycemia (>130 mg/dL) and persistent inpatient hyperglycemia (>48 hours) have been predictors of poor patient outcomes, including higher …
June 7, 2015
Use of eGlycemic Management System Safely Achieves Optimal Subcutaneous Glycemic Control With Low Hypoglycemia in Patients Without Diabetes
Use of eGlycemic Management System Safely Achieves Optimal Subcutaneous Glycemic Control With Low Hypoglycemia in Patients Without Diabetes Presentation American Diabetes Association Scientific Sessions Date June 2015 Authors Joseph Aloi,1 Robby Booth,2 Raymie McFarland,2 Jagdeesh Ullal,3 Melanie Mabrey2 Objective Hyperglycemia, regardless of its cause, is clearly associated with adverse outcomes in hospitalized patients. Hyperglycemia in patients with no known history …
May 16, 2015
eGlycemic Management Solution Safely Achieves Prescribed Glycemic Target with a Low Incidence of Hypoglycemia in Patients with Acute Myocardial Infarction in the Hospital
eGlycemic Management Solution Safely Achieves Prescribed Glycemic Target with a Low Incidence of Hypoglycemia in Patients with Acute Myocardial Infarction in the Hospital Presentation American Association of Clinical Endocrinologists Scientific & Clinical Congress Date May 2015 Authors Melanie Mabrey,1,2 Jagdeesh Ullal,3 Raymie McFarland,1 Robby Booth,1 Amy Henderson,1 Joseph Aloi4 Objective Acute myocardial infarction (AMI) patients presenting with hyperglycemia on admission …
eGlycemic Management Solution Safely Maintains Glycemic Targets With a Low Incidence of Hypoglycemia for Non-Diabetic CV Surgical Patients in the Inpatient Setting
eGlycemic Management Solution Safely Maintains Glycemic Targets With a Low Incidence of Hypoglycemia for Non-Diabetic CV Surgical Patients in the Inpatient Setting Presentation American Association of Clinical Endocrinologists Scientific & Clinical Congress Date May 2015 Authors Joseph Aloi,1 Paul Chidester,2 Jagdeesh Ullal,3 Amy Henderson,4 Robby Booth,4 Raymie McFarland4 Objective Patients without a prior diagnosis of diabetes admitted for cardiovascular (CV) …
May 8, 2015
Use of the eGlycemic Management Solution by Glytec Achieved ADA Glycemic Targets With Low Hypoglycemia for Patients Managed on Subcutaneous Insulin Therapy
Use of the eGlycemic Management Solution by Glytec Achieved ADA Glycemic Targets With Low Hypoglycemia for Patients Managed on Subcutaneous Insulin Therapy Presentation International Hospital Diabetes Meeting Date May 2015 Authors Melanie Mabrey, Joseph Aloi, Paul Chidester, Jagdeesh Ullal, Amy Henderson, Raymie McFarland, Robby Booth Objective American Diabetes Association guidelines recommend a basal bolus correction insulin regimen as the preferred …
Use of the eGlycemic Management Solution by Glytec Produces Less Hypoglycemia for Patients Managed on Subcutaneous Insulin Therapy
Use of the eGlycemic Management Solution by Glytec Produces Less Hypoglycemia for Patients Managed on Subcutaneous Insulin Therapy Presentation International Hospital Diabetes Meeting Date May 2015 Authors Melanie Mabrey, Joseph Aloi, Paul Chidester, Amy Henderson, Raymie McFarland, Robby Booth, Andrew Rhinehart Objective The American Diabetes Association guidelines recommend a basal bolus correction insulin regimen as the preferred method of treatment …
